VIAF

Virtual International Authority File

Search

Leader     00000nz a2200037n 45 0
001     WKP|Q56856199  (VIAF cluster)  (Authority/Source Record)
003     WKP
005     20241221010843.0
008     241221nneanz||abbn n and d
035 ‎‡a  (WKP)Q56856199‏
024 ‎‡a  0000-0002-8369-1577‏ ‎‡2  orcid‏
024 ‎‡a  9044084700‏ ‎‡2  scopus‏
035 ‎‡a  (OCoLC)Q56856199‏
100 0 ‎‡a  Ed C Wilson‏ ‎‡c  researcher‏ ‎‡9  en‏
375 ‎‡a  1‏ ‎‡2  iso5218‏
400 0 ‎‡a  Ed C Wilson‏ ‎‡c  wetenschapper‏ ‎‡9  nl‏
670 ‎‡a  Author's A cluster randomised controlled trial to evaluate the effectiveness and cost-effectiveness of the GoActive intervention to increase physical activity among adolescents aged 13-14 years.‏
670 ‎‡a  Author's A Decision Analysis Evaluating Screening for Kidney Cancer Using Focused Renal Ultrasound‏
670 ‎‡a  Author's A Modeling Study of the Cost-Effectiveness of a Risk-Stratified Surveillance Program for Melanoma in the United Kingdom‏
670 ‎‡a  Author's A practical guide to value of information analysis‏
670 ‎‡a  Author's A pragmatic single-blind randomised controlled trial and economic evaluation of the use of leukotriene receptor antagonists in primary care at steps 2 and 3 of the national asthma guidelines‏
670 ‎‡a  Author's A pragmatic single-blind randomised controlled trial and economic evaluation of the use of leukotriene receptor antagonists in primary care at steps 2 and 3 of the national asthma guidelines (ELEVATE study).‏
670 ‎‡a  Author's A randomised controlled trial of three very brief interventions for physical activity in primary care‏
670 ‎‡a  Author's A ‘telephone first’ approach to demand management in English general practice: a multimethod evaluation‏
670 ‎‡a  Author's Acceptability of the Medication Adherence for Patients Support intervention to improve adherence to patients prescribed medications for hypertension or comorbidities, as an adjunct to primary care: A qualitative study‏
670 ‎‡a  Author's Assessment of the Effectiveness and Cost-Effectiveness of Tailored Web- and Text-Based Smoking Cessation Support in Primary Care (iQuit in Practice II): Protocol for a Randomized Controlled Trial‏
670 ‎‡a  Author's Befriending carers of people with dementia: a cost utility analysis‏
670 ‎‡a  Author's Clinical and cost-effectiveness of a diabetes education and behavioural weight management programme versus a diabetes education programme in adults with a recent diagnosis of type 2 diabetes: study protocol for the Glucose Lowering through Weight ma‏
670 ‎‡a  Author's Clinical course, costs and predictive factors for response to treatment in carpal tunnel syndrome: the PALMS study protocol‏
670 ‎‡a  Author's Clinical effectiveness and cost-effectiveness of issuing longer versus shorter duration‏
670 ‎‡a  Author's Clinical effectiveness and cost-effectiveness of issuing longer versus shorter duration (3-month vs. 28-day) prescriptions in patients with chronic conditions: systematic review and economic modelling.‏
670 ‎‡a  Author's Controlling hypertension immediately post stroke: a cost utility analysis of a pilot randomised controlled trial.‏
670 ‎‡a  Author's Cost Analysis of Noninvasive Blood-Based MicroRNA Testing Versus CT Scans for Follow-up in Patients With Testicular Germ-Cell Tumors‏
670 ‎‡a  Author's Cost-Effectiveness and Value of Information Analysis of Brief Interventions to Promote Physical Activity in Primary Care.‏
670 ‎‡a  Author's Cost effectiveness of imiquimod 5% cream compared with methyl aminolevulinate-based photodynamic therapy in the treatment of non-hyperkeratotic, non-hypertrophic actinic (solar) keratoses: a decision tree model.‏
670 ‎‡a  Author's Cost-effectiveness of intensive multifactorial treatment compared with routine care for individuals with screen-detected Type 2 diabetes: analysis of the ADDITION-UK cluster-randomized controlled trial‏
670 ‎‡a  Author's Cost Effectiveness of Leukotriene Receptor Antagonists versus Inhaled Corticosteroids for Initial Asthma Controller Therapy‏
670 ‎‡a  Author's Cost Effectiveness of Leukotriene Receptor Antagonists versus Long-Acting Beta-2 Agonists as Add-On Therapy to Inhaled Corticosteroids for Asthma‏
670 ‎‡a  Author's DELTA2 guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial‏
670 ‎‡a  Author's Determining in-patient diabetes treatment satisfaction in the UK-the DIPSat study‏
670 ‎‡a  Author's Developing a prioritisation framework in an English Primary Care Trust.‏
670 ‎‡a  Author's Does self-monitoring and self-management of blood pressure after stroke or transient ischemic attack improve control? TEST-BP, a randomized controlled trial‏
670 ‎‡a  Author's Economic evaluations based on decision models: A response to Muston et al‏
670 ‎‡a  Author's Effect of adding a diagnostic aid to best practice to manage suspicious pigmented lesions in primary care: randomised controlled trial.‏
670 ‎‡a  Author's Effectiveness and cost-effectiveness of a very brief physical activity intervention delivered in NHS Health Checks (VBI Trial): study protocol for a randomised controlled trial.‏
670 ‎‡a  Author's Effectiveness and cost-effectiveness of the GoActive intervention to increase physical activity among UK adolescents: A cluster randomised controlled trial‏
670 ‎‡a  Author's Effectiveness of a behavioural intervention to prevent excessive weight gain during infancy (The Baby Milk Trial): study protocol for a randomised controlled trial‏
670 ‎‡a  Author's Efficient Research Design: Using Value-of-Information Analysis to Estimate the Optimal Mix of Top-down and Bottom-up Costing Approaches in an Economic Evaluation alongside a Clinical Trial‏
670 ‎‡a  Author's Evaluation of a very brief pedometer-based physical activity intervention delivered in NHS Health Checks in England: The VBI randomised controlled trial‏
670 ‎‡a  Author's Evaluation of telephone first approach to demand management in English general practice: observational study.‏
670 ‎‡a  Author's Expert Elicitation of Multinomial Probabilities for Decision-Analytic Modeling: An Application to Rates of Disease Progression in Undiagnosed and Untreated Melanoma‏
670 ‎‡a  Author's From Evidence-Based Economics to Economics-Based Evidence: Using Systematic Review to Inform the Design of Future Research‏
670 ‎‡a  Author's Home-based medication review in older people: is it cost effective?‏
670 ‎‡a  Author's Incremental Costs and Cost Effectiveness of Intensive Treatment in Individuals with Type 2 Diabetes Detected by Screening in the ADDITION-UK Trial: An Update with Empirical Trial-Based Cost Data.‏
670 ‎‡a  Author's Is sustained virological response a marker of treatment efficacy in patients with chronic hepatitis C viral infection with no response or relapse to previous antiviral intervention?‏
670 ‎‡a  Author's Leukotriene antagonists as first-line or add-on asthma-controller therapy.‏
670 ‎‡a  Author's Long-Term Costs and Health Consequences of Issuing Shorter Duration Prescriptions for Patients with Chronic Health Conditions in the English NHS.‏
670 ‎‡a  Author's Meta-analysis of randomized controlled trials on the safety and effectiveness of early versus delayed laparoscopic cholecystectomy for acute cholecystitis.‏
670 ‎‡a  Author's Patients' use and views of real-time feedback technology in general practice‏
670 ‎‡a  Author's Performance of the UKPDS outcomes model for prediction of myocardial infarction and stroke in the ADDITION-Europe trial cohort‏
670 ‎‡a  Author's Practical help for specifying the target difference in sample size calculations for RCTs: the DELTA2 five-stage study, including a workshop‏
670 ‎‡a  Author's Pragmatic randomised controlled trial to evaluate the effectiveness and cost effectiveness of a multi-component intervention to reduce substance use and risk-taking behaviour in adolescents involved in the criminal justice system: A trial protocol (‏
670 ‎‡a  Author's PreImplantation Trial of Histopathology In renal Allografts‏
670 ‎‡a  Author's PreImplantation Trial of Histopathology In renal Allografts (PITHIA): a stepped-wedge cluster randomised controlled trial protocol‏
670 ‎‡a  Author's Prioritizing health technologies in a Primary Care Trust‏
670 ‎‡a  Author's Prognostic factors for response to treatment by corticosteroid injection or surgery in carpal tunnel syndrome (palms study): A prospective multicenter cohort study‏
670 ‎‡a  Author's Protocol for the MoleMate UK Trial: a randomised controlled trial of the MoleMate system in the management of pigmented skin lesions in primary care [ISRCTN 79932379].‏
670 ‎‡a  Author's Randomised controlled trial of a theory-based behavioural intervention to reduce formula milk intake‏
670 ‎‡a  Author's Research: increasing value, reducing waste‏
670 ‎‡a  Author's Screening for breech presentation using universal late-pregnancy ultrasonography: A prospective cohort study and cost effectiveness analysis‏
670 ‎‡a  Author's Self-Monitoring and Management of Blood Pressure in Patients with Stroke or TIA: An Economic Evaluation of TEST-BP, A Randomised Controlled Trial‏
670 ‎‡a  Author's Surveillance arterioveNous fistulAs using ultRasound (SONAR) trial in haemodialysis patients: a study protocol for a multicentre observational study‏
670 ‎‡a  Author's The cost-effectiveness of a novel SIAscopic diagnostic aid for the management of pigmented skin lesions in primary care: a decision-analytic model.‏
670 ‎‡a  Author's The cost-effectiveness of mycophenolate mofetil as firstline therapy in active lupus nephritis‏
670 ‎‡a  Author's The cost-effectiveness of universal late-pregnancy screening for macrosomia in nulliparous women: a decision analysis‏
670 ‎‡a  Author's The cost to the United Kingdom National Health Service of managing erectile dysfunction: the impact of sildenafil and prescribing restrictions.‏
670 ‎‡a  Author's The costs to the NHS of multiple births after IVF treatment in the UK.‏
670 ‎‡a  Author's The development and feasibility of a randomised family-based physical activity promotion intervention: the Families Reporting Every Step to Health‏
670 ‎‡a  Author's The development and feasibility of a randomised family-based physical activity promotion intervention: the Families Reporting Every Step to Health (FRESH) study‏
670 ‎‡a  Author's The Long-Term Cost to the UK NHS and Social Services of Different Durations of IV Thiamine (Vitamin B1) for Chronic Alcohol Misusers with Symptoms of Wernicke's Encephalopathy Presenting at the Emergency Department‏
670 ‎‡a  Author's Transparency in Decision Modelling: What, Why, Who and How?‏
670 ‎‡a  Author's Using economic analyses for local priority setting : the population cost-impact approach.‏
670 ‎‡a  Author's When and how to update systematic reviews: consensus and checklist‏
909 ‎‡a  (orcid) 0000000283691577‏ ‎‡9  1‏
909 ‎‡a  (scopus) 9044084700‏ ‎‡9  1‏
919 ‎‡a  effectivenessofabehaviouralinterventiontopreventexcessiveweightgainduringinfancythebabymilktrialstudyprotocolforarandomisedcontrolledtrial‏ ‎‡A  Effectiveness of a behavioural intervention to prevent excessive weight gain during infancy (The Baby Milk Trial): study protocol for a randomised controlled trial‏ ‎‡9  1‏
919 ‎‡a  efficientresearchdesignusingvalueofinformationanalysistoestimatetheoptimal1009oftopdownandbottomupcostingapproachesinaneconomicevaluationalongsideaclinicaltrial‏ ‎‡A  Efficient Research Design: Using Value-of-Information Analysis to Estimate the Optimal Mix of Top-down and Bottom-up Costing Approaches in an Economic Evaluation alongside a Clinical Trial‏ ‎‡9  1‏
919 ‎‡a  evaluationofaverybriefpedometerbasedphysicalactivityinterventiondeliveredinnhshealthchecksinenglandthevbirandomisedcontrolledtrial‏ ‎‡A  Evaluation of a very brief pedometer-based physical activity intervention delivered in NHS Health Checks in England: The VBI randomised controlled trial‏ ‎‡9  1‏
919 ‎‡a  evaluationoftelephone1approachtodemandmanagementinenglishgeneralpracticeobservationalstudy‏ ‎‡A  Evaluation of telephone first approach to demand management in English general practice: observational study.‏ ‎‡9  1‏
919 ‎‡a  expertelicitationofmultinomialprobabilitiesfordecisionanalyticmodelinganapplicationtoratesofdiseaseprogressioninundiagnosedanduntreatedmelanoma‏ ‎‡A  Expert Elicitation of Multinomial Probabilities for Decision-Analytic Modeling: An Application to Rates of Disease Progression in Undiagnosed and Untreated Melanoma‏ ‎‡9  1‏
919 ‎‡a  whenandhowtoupdatesystematicreviewsconsensusandchecklist‏ ‎‡A  When and how to update systematic reviews: consensus and checklist‏ ‎‡9  1‏
919 ‎‡a  usingeconomicanalysesforlocalprioritysettingthepopulationcostimpactapproach‏ ‎‡A  Using economic analyses for local priority setting : the population cost-impact approach.‏ ‎‡9  1‏
919 ‎‡a  transparencyindecisionmodellingwhatwhywhoandhow‏ ‎‡A  Transparency in Decision Modelling: What, Why, Who and How?‏ ‎‡9  1‏
919 ‎‡a  longtermcosttotheuknhsandsocialservicesofdifferentdurationsof4thiaminevitaminb1forchronicalcoholmisuserswithsymptomsofwernickesencephalopathypresentingattheemergencydepartment‏ ‎‡A  The Long-Term Cost to the UK NHS and Social Services of Different Durations of IV Thiamine (Vitamin B1) for Chronic Alcohol Misusers with Symptoms of Wernicke's Encephalopathy Presenting at the Emergency Department‏ ‎‡9  1‏
919 ‎‡a  developmentandfeasibilityofarandomisedfamilybasedphysicalactivitypromotioninterventionthefamiliesreportingeverysteptohealthfreshstudy‏ ‎‡A  The development and feasibility of a randomised family-based physical activity promotion intervention: the Families Reporting Every Step to Health (FRESH) study‏ ‎‡9  1‏
919 ‎‡a  developmentandfeasibilityofarandomisedfamilybasedphysicalactivitypromotioninterventionthefamiliesreportingeverysteptohealth‏ ‎‡A  The development and feasibility of a randomised family-based physical activity promotion intervention: the Families Reporting Every Step to Health‏ ‎‡9  1‏
919 ‎‡a  coststothenhsofmultiplebirthsafterivftreatmentintheuk‏ ‎‡A  The costs to the NHS of multiple births after IVF treatment in the UK.‏ ‎‡9  1‏
919 ‎‡a  costtotheunitedkingdomnationalhealthserviceofmanagingerectiledysfunctiontheimpactofsildenafilandprescribingrestrictions‏ ‎‡A  The cost to the United Kingdom National Health Service of managing erectile dysfunction: the impact of sildenafil and prescribing restrictions.‏ ‎‡9  1‏
919 ‎‡a  costeffectivenessofuniversallatepregnancyscreeningformacrosomiainnulliparouswomenadecisionanalysis‏ ‎‡A  The cost-effectiveness of universal late-pregnancy screening for macrosomia in nulliparous women: a decision analysis‏ ‎‡9  1‏
919 ‎‡a  costeffectivenessofmycophenolatemofetilasfirstlinetherapyinactivelupusnephritis‏ ‎‡A  The cost-effectiveness of mycophenolate mofetil as firstline therapy in active lupus nephritis‏ ‎‡9  1‏
919 ‎‡a  costeffectivenessofanovelsiascopicdiagnosticaidforthemanagementofpigmentedskinlesionsinprimarycareadecisionanalyticmodel‏ ‎‡A  The cost-effectiveness of a novel SIAscopic diagnostic aid for the management of pigmented skin lesions in primary care: a decision-analytic model.‏ ‎‡9  1‏
919 ‎‡a  surveillancearteriovenousfistulasusingultrasoundsonartrialinhaemodialysispatientsastudyprotocolforamulticentreobservationalstudy‏ ‎‡A  Surveillance arterioveNous fistulAs using ultRasound (SONAR) trial in haemodialysis patients: a study protocol for a multicentre observational study‏ ‎‡9  1‏
919 ‎‡a  selfmonitoringandmanagementofbloodpressureinpatientswithstrokeortiaaneconomicevaluationoftestbparandomisedcontrolledtrial‏ ‎‡A  Self-Monitoring and Management of Blood Pressure in Patients with Stroke or TIA: An Economic Evaluation of TEST-BP, A Randomised Controlled Trial‏ ‎‡9  1‏
919 ‎‡a  screeningforbreechpresentationusinguniversallatepregnancyultrasonographyaprospectivecohortstudyandcosteffectivenessanalysis‏ ‎‡A  Screening for breech presentation using universal late-pregnancy ultrasonography: A prospective cohort study and cost effectiveness analysis‏ ‎‡9  1‏
919 ‎‡a  researchincreasingvaluereducingwaste‏ ‎‡A  Research: increasing value, reducing waste‏ ‎‡9  1‏
919 ‎‡a  randomisedcontrolledtrialofatheorybasedbehaviouralinterventiontoreduceformulamilkintake‏ ‎‡A  Randomised controlled trial of a theory-based behavioural intervention to reduce formula milk intake‏ ‎‡9  1‏
919 ‎‡a  protocolforthemolemateuktrialarandomisedcontrolledtrialofthemolematesysteminthemanagementofpigmentedskinlesionsinprimarycare‏ ‎‡A  Protocol for the MoleMate UK Trial: a randomised controlled trial of the MoleMate system in the management of pigmented skin lesions in primary care [ISRCTN 79932379].‏ ‎‡9  1‏
919 ‎‡a  prognosticfactorsforresponsetotreatmentbycorticosteroidinjectionorsurgeryincarpaltunnelsyndromepalmsstudyaprospectivemulticentercohortstudy‏ ‎‡A  Prognostic factors for response to treatment by corticosteroid injection or surgery in carpal tunnel syndrome (palms study): A prospective multicenter cohort study‏ ‎‡9  1‏
919 ‎‡a  prioritizinghealthtechnologiesinaprimarycaretrust‏ ‎‡A  Prioritizing health technologies in a Primary Care Trust‏ ‎‡9  1‏
919 ‎‡a  preimplantationtrialofhistopathologyinrenalallograftspithiaasteppedwedgeclusterrandomisedcontrolledtrialprotocol‏ ‎‡A  PreImplantation Trial of Histopathology In renal Allografts (PITHIA): a stepped-wedge cluster randomised controlled trial protocol‏ ‎‡9  1‏
919 ‎‡a  preimplantationtrialofhistopathologyinrenalallografts‏ ‎‡A  PreImplantation Trial of Histopathology In renal Allografts‏ ‎‡9  1‏
919 ‎‡a  pragmaticrandomisedcontrolledtrialtoevaluatetheeffectivenessandcosteffectivenessofamulticomponentinterventiontoreducesubstanceuseandrisktakingbehaviourinadolescentsinvolvedinthecriminaljusticesystematrialprotocol‏ ‎‡A  Pragmatic randomised controlled trial to evaluate the effectiveness and cost effectiveness of a multi-component intervention to reduce substance use and risk-taking behaviour in adolescents involved in the criminal justice system: A trial protocol (‏ ‎‡9  1‏
919 ‎‡a  practicalhelpforspecifyingthetargetdifferenceinsamplesizecalculationsforrctsthedelta25stagestudyincludingaworkshop‏ ‎‡A  Practical help for specifying the target difference in sample size calculations for RCTs: the DELTA2 five-stage study, including a workshop‏ ‎‡9  1‏
919 ‎‡a  performanceoftheukpdsoutcomesmodelforpredictionofmyocardialinfarctionandstrokeintheadditioneuropetrialcohort‏ ‎‡A  Performance of the UKPDS outcomes model for prediction of myocardial infarction and stroke in the ADDITION-Europe trial cohort‏ ‎‡9  1‏
919 ‎‡a  patientsuseandviewsofrealtimefeedbacktechnologyingeneralpractice‏ ‎‡A  Patients' use and views of real-time feedback technology in general practice‏ ‎‡9  1‏
919 ‎‡a  metaanalysisofrandomizedcontrolledtrialsonthesafetyandeffectivenessofearlyversusdelayedlaparoscopiccholecystectomyforacutecholecystitis‏ ‎‡A  Meta-analysis of randomized controlled trials on the safety and effectiveness of early versus delayed laparoscopic cholecystectomy for acute cholecystitis.‏ ‎‡9  1‏
919 ‎‡a  longtermcostsandhealthconsequencesofissuingshorterdurationprescriptionsforpatientswithchronichealthconditionsintheenglishnhs‏ ‎‡A  Long-Term Costs and Health Consequences of Issuing Shorter Duration Prescriptions for Patients with Chronic Health Conditions in the English NHS.‏ ‎‡9  1‏
919 ‎‡a  leukotrieneantagonistsas1lineoraddonasthmacontrollertherapy‏ ‎‡A  Leukotriene antagonists as first-line or add-on asthma-controller therapy.‏ ‎‡9  1‏
919 ‎‡a  issustainedvirologicalresponseamarkeroftreatmentefficacyinpatientswithchronichepatitis100viralinfectionwithnoresponseorrelapsetopreviousantiviralintervention‏ ‎‡A  Is sustained virological response a marker of treatment efficacy in patients with chronic hepatitis C viral infection with no response or relapse to previous antiviral intervention?‏ ‎‡9  1‏
919 ‎‡a  incrementalcostsandcosteffectivenessofintensivetreatmentinindividualswithtype2diabetesdetectedbyscreeningintheadditionuktrialanupdatewithempiricaltrialbasedcostdata‏ ‎‡A  Incremental Costs and Cost Effectiveness of Intensive Treatment in Individuals with Type 2 Diabetes Detected by Screening in the ADDITION-UK Trial: An Update with Empirical Trial-Based Cost Data.‏ ‎‡9  1‏
919 ‎‡a  clusterrandomisedcontrolledtrialtoevaluatetheeffectivenessandcosteffectivenessofthegoactiveinterventiontoincreasephysicalactivityamongadolescentsaged1314years‏ ‎‡A  A cluster randomised controlled trial to evaluate the effectiveness and cost-effectiveness of the GoActive intervention to increase physical activity among adolescents aged 13-14 years.‏ ‎‡9  1‏
919 ‎‡a  decisionanalysisevaluatingscreeningforkidneycancerusingfocusedrenalultrasound‏ ‎‡A  A Decision Analysis Evaluating Screening for Kidney Cancer Using Focused Renal Ultrasound‏ ‎‡9  1‏
919 ‎‡a  modelingstudyofthecosteffectivenessofariskstratifiedsurveillanceprogramformelanomaintheunitedkingdom‏ ‎‡A  A Modeling Study of the Cost-Effectiveness of a Risk-Stratified Surveillance Program for Melanoma in the United Kingdom‏ ‎‡9  1‏
919 ‎‡a  practicalguidetovalueofinformationanalysis‏ ‎‡A  A practical guide to value of information analysis‏ ‎‡9  1‏
919 ‎‡a  pragmaticsingleblindrandomisedcontrolledtrialandeconomicevaluationoftheuseofleukotrienereceptorantagonistsinprimarycareatsteps2and3ofthenationalasthmaguidelines‏ ‎‡A  A pragmatic single-blind randomised controlled trial and economic evaluation of the use of leukotriene receptor antagonists in primary care at steps 2 and 3 of the national asthma guidelines‏ ‎‡9  1‏
919 ‎‡a  homebasedmedicationreviewinolderpeopleisitcosteffective‏ ‎‡A  Home-based medication review in older people: is it cost effective?‏ ‎‡9  1‏
919 ‎‡a  pragmaticsingleblindrandomisedcontrolledtrialandeconomicevaluationoftheuseofleukotrienereceptorantagonistsinprimarycareatsteps2and3ofthenationalasthmaguidelineselevatestudy‏ ‎‡A  A pragmatic single-blind randomised controlled trial and economic evaluation of the use of leukotriene receptor antagonists in primary care at steps 2 and 3 of the national asthma guidelines (ELEVATE study).‏ ‎‡9  1‏
919 ‎‡a  randomisedcontrolledtrialof3verybriefinterventionsforphysicalactivityinprimarycare‏ ‎‡A  A randomised controlled trial of three very brief interventions for physical activity in primary care‏ ‎‡9  1‏
919 ‎‡a  telephone1approachtodemandmanagementinenglishgeneralpracticeamultimethodevaluation‏ ‎‡A  A ‘telephone first’ approach to demand management in English general practice: a multimethod evaluation‏ ‎‡9  1‏
919 ‎‡a  acceptabilityofthemedicationadherenceforpatientssupportinterventiontoimproveadherencetopatientsprescribedmedicationsforhypertensionorcomorbiditiesasanadjuncttoprimarycareaqualitativestudy‏ ‎‡A  Acceptability of the Medication Adherence for Patients Support intervention to improve adherence to patients prescribed medications for hypertension or comorbidities, as an adjunct to primary care: A qualitative study‏ ‎‡9  1‏
919 ‎‡a  assessmentoftheeffectivenessandcosteffectivenessoftailoredwebandtextbasedsmokingcessationsupportinprimarycareiquitinpractice2protocolforarandomizedcontrolledtrial‏ ‎‡A  Assessment of the Effectiveness and Cost-Effectiveness of Tailored Web- and Text-Based Smoking Cessation Support in Primary Care (iQuit in Practice II): Protocol for a Randomized Controlled Trial‏ ‎‡9  1‏
919 ‎‡a  befriendingcarersofpeoplewithdementiaacostutilityanalysis‏ ‎‡A  Befriending carers of people with dementia: a cost utility analysis‏ ‎‡9  1‏
919 ‎‡a  clinicalandcosteffectivenessofadiabeteseducationandbehaviouralweightmanagementprogrammeversusadiabeteseducationprogrammeinadultswitharecentdiagnosisoftype2diabetesstudyprotocolfortheglucoseloweringthroughweightma‏ ‎‡A  Clinical and cost-effectiveness of a diabetes education and behavioural weight management programme versus a diabetes education programme in adults with a recent diagnosis of type 2 diabetes: study protocol for the Glucose Lowering through Weight ma‏ ‎‡9  1‏
919 ‎‡a  clinicalcoursecostsandpredictivefactorsforresponsetotreatmentincarpaltunnelsyndromethepalmsstudyprotocol‏ ‎‡A  Clinical course, costs and predictive factors for response to treatment in carpal tunnel syndrome: the PALMS study protocol‏ ‎‡9  1‏
919 ‎‡a  clinicaleffectivenessandcosteffectivenessofissuinglongerversusshorterduration‏ ‎‡A  Clinical effectiveness and cost-effectiveness of issuing longer versus shorter duration‏ ‎‡9  1‏
919 ‎‡a  clinicaleffectivenessandcosteffectivenessofissuinglongerversusshorterduration3monthvs28dayprescriptionsinpatientswithchronicconditionssystematicreviewandeconomicmodelling‏ ‎‡A  Clinical effectiveness and cost-effectiveness of issuing longer versus shorter duration (3-month vs. 28-day) prescriptions in patients with chronic conditions: systematic review and economic modelling.‏ ‎‡9  1‏
919 ‎‡a  controllinghypertensionimmediatelypoststrokeacostutilityanalysisofapilotrandomisedcontrolledtrial‏ ‎‡A  Controlling hypertension immediately post stroke: a cost utility analysis of a pilot randomised controlled trial.‏ ‎‡9  1‏
919 ‎‡a  costanalysisofnoninvasivebloodbasedmicrornatestingversusctscansforfollowupinpatientswithtesticulargermcelltumors‏ ‎‡A  Cost Analysis of Noninvasive Blood-Based MicroRNA Testing Versus CT Scans for Follow-up in Patients With Testicular Germ-Cell Tumors‏ ‎‡9  1‏
919 ‎‡a  costeffectivenessandvalueofinformationanalysisofbriefinterventionstopromotephysicalactivityinprimarycare‏ ‎‡A  Cost-Effectiveness and Value of Information Analysis of Brief Interventions to Promote Physical Activity in Primary Care.‏ ‎‡9  1‏
919 ‎‡a  costeffectivenessofimiquimod5creamcomparedwithmethylaminolevulinatebasedphotodynamictherapyinthetreatmentofnonhyperkeratoticnonhypertrophicactinicsolarkeratosesadecisiontreemodel‏ ‎‡A  Cost effectiveness of imiquimod 5% cream compared with methyl aminolevulinate-based photodynamic therapy in the treatment of non-hyperkeratotic, non-hypertrophic actinic (solar) keratoses: a decision tree model.‏ ‎‡9  1‏
919 ‎‡a  costeffectivenessofintensivemultifactorialtreatmentcomparedwithroutinecareforindividualswithscreendetectedtype2diabetesanalysisoftheadditionukclusterrandomizedcontrolledtrial‏ ‎‡A  Cost-effectiveness of intensive multifactorial treatment compared with routine care for individuals with screen-detected Type 2 diabetes: analysis of the ADDITION-UK cluster-randomized controlled trial‏ ‎‡9  1‏
919 ‎‡a  costeffectivenessofleukotrienereceptorantagonistsversusinhaledcorticosteroidsforinitialasthmacontrollertherapy‏ ‎‡A  Cost Effectiveness of Leukotriene Receptor Antagonists versus Inhaled Corticosteroids for Initial Asthma Controller Therapy‏ ‎‡9  1‏
919 ‎‡a  costeffectivenessofleukotrienereceptorantagonistsversuslongactingbeta2agonistsasaddontherapytoinhaledcorticosteroidsforasthma‏ ‎‡A  Cost Effectiveness of Leukotriene Receptor Antagonists versus Long-Acting Beta-2 Agonists as Add-On Therapy to Inhaled Corticosteroids for Asthma‏ ‎‡9  1‏
919 ‎‡a  delta2guidanceonchoosingthetargetdifferenceandundertakingandreportingthesamplesizecalculationforarandomisedcontrolledtrial‏ ‎‡A  DELTA2 guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial‏ ‎‡9  1‏
919 ‎‡a  fromevidencebasedeconomicstoeconomicsbasedevidenceusingsystematicreviewtoinformthedesignoffutureresearch‏ ‎‡A  From Evidence-Based Economics to Economics-Based Evidence: Using Systematic Review to Inform the Design of Future Research‏ ‎‡9  1‏
919 ‎‡a  determininginpatientdiabetestreatmentsatisfactionintheukthedipsatstudy‏ ‎‡A  Determining in-patient diabetes treatment satisfaction in the UK-the DIPSat study‏ ‎‡9  1‏
919 ‎‡a  developingaprioritisationframeworkinanenglishprimarycaretrust‏ ‎‡A  Developing a prioritisation framework in an English Primary Care Trust.‏ ‎‡9  1‏
919 ‎‡a  doesselfmonitoringandselfmanagementofbloodpressureafterstrokeortransientischemicattackimprovecontroltestbparandomizedcontrolledtrial‏ ‎‡A  Does self-monitoring and self-management of blood pressure after stroke or transient ischemic attack improve control? TEST-BP, a randomized controlled trial‏ ‎‡9  1‏
919 ‎‡a  economicevaluationsbasedondecisionmodelsaresponsetomustonetal‏ ‎‡A  Economic evaluations based on decision models: A response to Muston et al‏ ‎‡9  1‏
919 ‎‡a  effectofaddingadiagnosticaidtobestpracticetomanagesuspiciouspigmentedlesionsinprimarycarerandomisedcontrolledtrial‏ ‎‡A  Effect of adding a diagnostic aid to best practice to manage suspicious pigmented lesions in primary care: randomised controlled trial.‏ ‎‡9  1‏
919 ‎‡a  effectivenessandcosteffectivenessofaverybriefphysicalactivityinterventiondeliveredinnhshealthchecksvbitrialstudyprotocolforarandomisedcontrolledtrial‏ ‎‡A  Effectiveness and cost-effectiveness of a very brief physical activity intervention delivered in NHS Health Checks (VBI Trial): study protocol for a randomised controlled trial.‏ ‎‡9  1‏
919 ‎‡a  effectivenessandcosteffectivenessofthegoactiveinterventiontoincreasephysicalactivityamongukadolescentsaclusterrandomisedcontrolledtrial‏ ‎‡A  Effectiveness and cost-effectiveness of the GoActive intervention to increase physical activity among UK adolescents: A cluster randomised controlled trial‏ ‎‡9  1‏
946 ‎‡a  b‏ ‎‡9  1‏
996 ‎‡2  BIBSYS|90184211‏
996 ‎‡2  NII|DA04425249‏
996 ‎‡2  BNF|10580727‏
996 ‎‡2  SUDOC|079546196‏
996 ‎‡2  DNB|135165989‏
996 ‎‡2  SUDOC|133425614‏
996 ‎‡2  J9U|987007279061805171‏
996 ‎‡2  NTA|069856397‏
996 ‎‡2  BNF|13815621‏
996 ‎‡2  NUKAT|n 2005033526‏
996 ‎‡2  SUDOC|028972236‏
996 ‎‡2  LC|n 2008162169‏
996 ‎‡2  SUDOC|147763746‏
996 ‎‡2  DNB|170716309‏
996 ‎‡2  SUDOC|260593214‏
996 ‎‡2  ISNI|0000000074291630‏
996 ‎‡2  LC|n 92024921‏
996 ‎‡2  SUDOC|276999983‏
996 ‎‡2  LC|no2024058101‏
996 ‎‡2  ISNI|0000000050810600‏
996 ‎‡2  NII|DA05982502‏
996 ‎‡2  LNB|LNC10-000038982‏
996 ‎‡2  N6I|vtls001318131‏
996 ‎‡2  ISNI|0000000039157364‏
996 ‎‡2  ISNI|0000000396198279‏
996 ‎‡2  NII|DA1049266X‏
996 ‎‡2  NKC|mub2010589739‏
996 ‎‡2  NTA|070952175‏
996 ‎‡2  RERO|A022848718‏
996 ‎‡2  NLA|000035612188‏
996 ‎‡2  BIBSYS|2047140‏
996 ‎‡2  NLA|000035412599‏
996 ‎‡2  DNB|1146112718‏
996 ‎‡2  NII|DA01051663‏
996 ‎‡2  SUDOC|06030362X‏
996 ‎‡2  ISNI|0000000046917763‏
996 ‎‡2  N6I|vtls000065413‏
996 ‎‡2  SELIBR|326945‏
996 ‎‡2  NTA|070057850‏
996 ‎‡2  LC|n 2006025279‏
996 ‎‡2  LC|n 2021009692‏
996 ‎‡2  BIBSYS|90511048‏
996 ‎‡2  JPG|500012028‏
996 ‎‡2  NUKAT|n 2010056673‏
996 ‎‡2  ISNI|0000000083656814‏
996 ‎‡2  ISNI|000000003294949X‏
996 ‎‡2  LC|n 50015519‏
996 ‎‡2  DNB|172676223‏
996 ‎‡2  LC|n 88172401‏
996 ‎‡2  LC|n 84019121‏
996 ‎‡2  LC|n 83074117‏
996 ‎‡2  LC|n 79094539‏
996 ‎‡2  ISNI|0000000039140212‏
996 ‎‡2  KRNLK|KAC199630213‏
996 ‎‡2  KRNLK|KAC199630212‏
996 ‎‡2  DNB|1136617817‏
996 ‎‡2  LIH|LNB:_b_C_t_;=B_p_‏
996 ‎‡2  BNE|XX1160605‏
996 ‎‡2  LC|no 00004332‏
996 ‎‡2  NLA|000036544419‏
996 ‎‡2  NII|DA03162960‏
996 ‎‡2  ISNI|0000000023355614‏
996 ‎‡2  PLWABN|9810542032305606‏
996 ‎‡2  J9U|987007275596105171‏
996 ‎‡2  DBC|87097969093035‏
996 ‎‡2  ISNI|0000000083799321‏
996 ‎‡2  BAV|495_237754‏
996 ‎‡2  BNF|17166994‏
996 ‎‡2  LC|n 79043459‏
996 ‎‡2  NUKAT|n 2011242334‏
996 ‎‡2  BNF|11465741‏
996 ‎‡2  NSK|000098400‏
996 ‎‡2  JPG|500052061‏
996 ‎‡2  KRNLK|KAC200001963‏
996 ‎‡2  LC|no2007036252‏
996 ‎‡2  BIBSYS|90574346‏
996 ‎‡2  LC|n 87821583‏
996 ‎‡2  NKC|ntk2014825515‏
996 ‎‡2  JPG|500106625‏
996 ‎‡2  LC|n 2008043403‏
996 ‎‡2  ISNI|0000000122143713‏
996 ‎‡2  RERO|A014287851‏
996 ‎‡2  LC|n 86034969‏
996 ‎‡2  CAOONL|ncf10323199‏
996 ‎‡2  PLWABN|9810656966705606‏
996 ‎‡2  N6I|vtls001234975‏
996 ‎‡2  LC|no 89014795‏
996 ‎‡2  LC|no 90018294‏
996 ‎‡2  NTA|068948522‏
996 ‎‡2  RERO|A022883218‏
996 ‎‡2  ISNI|0000000032725664‏
996 ‎‡2  ISNI|0000000442511669‏
996 ‎‡2  PTBNP|48620‏
996 ‎‡2  SUDOC|079326463‏
996 ‎‡2  SUDOC|187540330‏
996 ‎‡2  ISNI|0000000030485580‏
996 ‎‡2  RERO|A012348431‏
996 ‎‡2  LC|no2016015147‏
996 ‎‡2  ISNI|0000000025396874‏
996 ‎‡2  ISNI|0000000133581946‏
996 ‎‡2  J9U|987007273851905171‏
996 ‎‡2  ISNI|0000000454007371‏
996 ‎‡2  BNF|16943714‏
996 ‎‡2  ISNI|0000000074853082‏
996 ‎‡2  LC|n 2012073617‏
996 ‎‡2  LC|n 95074114‏
996 ‎‡2  NKC|jn19990009176‏
996 ‎‡2  NKC|jn19990009175‏
996 ‎‡2  NKC|jn19990009174‏
996 ‎‡2  DNB|1188563017‏
996 ‎‡2  J9U|987007284241205171‏
996 ‎‡2  DNB|1172764387‏
996 ‎‡2  NTA|068275951‏
996 ‎‡2  CAOONL|ncf10143985‏
996 ‎‡2  LC|n 87907103‏
996 ‎‡2  DNB|129938966X‏
996 ‎‡2  NDL|00527373‏
996 ‎‡2  BNF|11929264‏
996 ‎‡2  ISNI|0000000455154349‏
996 ‎‡2  BNF|11929263‏
996 ‎‡2  ISNI|0000000350491816‏
996 ‎‡2  CAOONL|ncf10436647‏
996 ‎‡2  DNB|1272377792‏
996 ‎‡2  BIBSYS|90071576‏
996 ‎‡2  B2Q|0000092269‏
996 ‎‡2  BNC|981058515065106706‏
996 ‎‡2  PLWABN|9812830623005606‏
996 ‎‡2  N6I|vtls001886834‏
996 ‎‡2  SUDOC|13888143X‏
996 ‎‡2  DNB|1089352654‏
996 ‎‡2  ISNI|000000012280725X‏
996 ‎‡2  J9U|987007321023305171‏
996 ‎‡2  ISNI|0000000025565121‏
996 ‎‡2  LC|n 50015520‏
996 ‎‡2  LC|n 50015521‏
996 ‎‡2  NDL|00864791‏
996 ‎‡2  J9U|987007412710805171‏
996 ‎‡2  NII|DA07547388‏
996 ‎‡2  SUDOC|083235965‏
996 ‎‡2  SUDOC|185331246‏
996 ‎‡2  BNF|17995723‏
996 ‎‡2  LC|no2014066407‏
996 ‎‡2  LC|no2013133151‏
996 ‎‡2  ISNI|0000000038101414‏
996 ‎‡2  SUDOC|138876940‏
996 ‎‡2  LC|no 94036239‏
996 ‎‡2  BNC|981058512722906706‏
996 ‎‡2  SUDOC|125188633‏
996 ‎‡2  DNB|118633481‏
996 ‎‡2  LC|n 83120626‏
996 ‎‡2  BNF|11550558‏
996 ‎‡2  LC|nb2012014014‏
996 ‎‡2  JPG|500490352‏
996 ‎‡2  CAOONL|ncf11277501‏
996 ‎‡2  NDL|031224382‏
996 ‎‡2  PLWABN|9810615733005606‏
996 ‎‡2  NUKAT|n 2009117019‏
996 ‎‡2  LC|n 82085828‏
996 ‎‡2  LNB|LNC10-000239964‏
996 ‎‡2  PLWABN|9810572912005606‏
996 ‎‡2  ISNI|0000000497730797‏
996 ‎‡2  DNB|127850090‏
996 ‎‡2  ISNI|0000000036666673‏
996 ‎‡2  PTBNP|48615‏
996 ‎‡2  DNB|123973961‏
996 ‎‡2  NDL|001281086‏
996 ‎‡2  NTA|068374364‏
996 ‎‡2  BIBSYS|90730616‏
996 ‎‡2  ISNI|0000000402378090‏
996 ‎‡2  ISNI|0000000117368715‏
996 ‎‡2  DNB|119081229‏
996 ‎‡2  ISNI|0000000112354699‏
996 ‎‡2  B2Q|0000089843‏
996 ‎‡2  BIBSYS|90093019‏
996 ‎‡2  LC|no2019163050‏
996 ‎‡2  LIH|LNB:V-39496;=BR‏
996 ‎‡2  LC|no2016025062‏
996 ‎‡2  ISNI|0000000371368761‏
996 ‎‡2  LC|nb 99058273‏
996 ‎‡2  NUKAT|n 2022171865‏
996 ‎‡2  NII|DA19673812‏
996 ‎‡2  NUKAT|n 2005093158‏
996 ‎‡2  CAOONL|ncf10320911‏
996 ‎‡2  LC|no 93008656‏
996 ‎‡2  ISNI|0000000445150520‏
996 ‎‡2  LNB|LNC10-000249187‏
996 ‎‡2  PLWABN|9810575263105606‏
996 ‎‡2  BNF|12441848‏
996 ‎‡2  J9U|987007578748505171‏
996 ‎‡2  NUKAT|n 2012052238‏
996 ‎‡2  SUDOC|151004722‏
996 ‎‡2  LC|nr 93043106‏
996 ‎‡2  LC|n 2002105277‏
996 ‎‡2  NTA|072453958‏
996 ‎‡2  LC|n 92060865‏
996 ‎‡2  NUKAT|n 2007137539‏
996 ‎‡2  ISNI|0000000443635532‏
996 ‎‡2  SUDOC|030932769‏
996 ‎‡2  B2Q|0001139455‏
996 ‎‡2  SUDOC|069498962‏
996 ‎‡2  BNE|XX5700180‏
996 ‎‡2  ISNI|0000000078799837‏
996 ‎‡2  BIBSYS|90779168‏
996 ‎‡2  N6I|vtls001324581‏
996 ‎‡2  DNB|1198417471‏
996 ‎‡2  NTA|080188370‏
996 ‎‡2  RERO|A003978526‏
996 ‎‡2  LC|n 81150040‏
996 ‎‡2  NTA|422636185‏
996 ‎‡2  NSK|000235651‏
996 ‎‡2  BNF|14618482‏
996 ‎‡2  ISNI|000000050604532X‏
996 ‎‡2  SUDOC|148516696‏
996 ‎‡2  NLA|000035612182‏
996 ‎‡2  ISNI|0000000082645240‏
996 ‎‡2  PLWABN|9812829971305606‏
996 ‎‡2  NLA|000035612228‏
996 ‎‡2  ISNI|0000000114479997‏
996 ‎‡2  DNB|1157830927‏
996 ‎‡2  LC|no2011183662‏
996 ‎‡2  LIH|LNB:V-168694;=BU‏
996 ‎‡2  DNB|12803873X‏
996 ‎‡2  SUDOC|034194762‏
996 ‎‡2  DNB|1024094979‏
996 ‎‡2  ISNI|0000000081145746‏
996 ‎‡2  CAOONL|ncf10062601‏
996 ‎‡2  DNB|1019574801‏
996 ‎‡2  ISNI|0000000434637464‏
996 ‎‡2  B2Q|0000271002‏
996 ‎‡2  NLA|000036044482‏
996 ‎‡2  DNB|1205576452‏
996 ‎‡2  NDL|00551663‏
996 ‎‡2  LC|n 93124472‏
996 ‎‡2  SUDOC|225900602‏
996 ‎‡2  SELIBR|305985‏
996 ‎‡2  BNCHL|10000000000000000139950‏
996 ‎‡2  J9U|987007453528705171‏
996 ‎‡2  BNE|XX983537‏
996 ‎‡2  LC|nr 93013292‏
996 ‎‡2  ISNI|0000000500825560‏
996 ‎‡2  LC|n 2013040846‏
996 ‎‡2  SZ|12803873X‏
996 ‎‡2  LC|n 88258586‏
996 ‎‡2  SUDOC|083516964‏
996 ‎‡2  DNB|1253688575‏
996 ‎‡2  J9U|987007458712805171‏
996 ‎‡2  BNE|XX1723427‏
996 ‎‡2  ISNI|0000000117686983‏
996 ‎‡2  JPG|500247109‏
996 ‎‡2  SUDOC|086107100‏
997 ‎‡a  0 0 lived 0 0‏ ‎‡9  1‏